^
    Back
    Association details:
    Biomarker:CCR5 expression
    Cancer:Lung Adenocarcinoma
    Drug Class:Immunotherapy
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    Transl Cancer Res
    Title:

    Molecular markers that predict response to combined radiotherapy and immunotherapy in patients with lung adenocarcinoma: a bioinformatics analysis

    Published date:
    11/16/2023
    Excerpt:
    Among these genes, the expression of PTPRC, TLR8, and CCR5 was associated with responsiveness to immunotherapy after SBRT.
    DOI:
    10.21037/tcr-23-968